Myeloid cells as potential targets for immunotherapy in pediatric gliomas

Keyphrases

• Myeloid Cells 100%
• Pediatric Glioma 100%
• Pediatric Glioblastoma 80%
• Pediatric 60%
• Standard of Care 40%
• Immunosuppression 40%
• Central Nervous System Malignancies 40%
• Cell-to-cell 20%
• Microglia 20%
• Macrophages 20%
• Malignancy 20%
• Therapeutic Strategies 20%
• Cell-based 20%
• Tumor Microenvironment 20%
• Cell-derived 20%
• Dendritic Cells 20%
• Immune Therapy 20%
• Surgical Resection 20%
• 5-year Survival 20%
• Glioma Patients 20%
• Specific Mechanisms 20%
• Highly Aggressive 20%
• All Pediatric 20%
• Chemoradiation 20%
• Immunotherapeutic Approaches 20%
• Immunosuppressive Microenvironment 20%
• Glioma Tumor 20%
• Immune Checkpoint Inhibitors 20%
• Immunosuppressive Myeloid Cells 20%
• Monocytic Myeloid-derived Suppressor Cells (M-MDSCs) 20%

Immunology and Microbiology

• Immunotherapy 100%
• Myeloid 100%
• Immunosuppression 50%
• Immunosuppressive Drug 50%
• Central Nervous System 50%
• Macrophage 25%
• Myeloid-Derived Suppressor Cell 25%
• Dendritic Cell 25%
• Microglia 25%
• Survival Rate 25%
• Cell-Based Vaccine 25%
• Immune Checkpoint Inhibitor 25%